355 related articles for article (PubMed ID: 3496428)
1. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
2. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
3. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
[TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant.
Spence AM; Muzi M; Graham MM; O'Sullivan F; Krohn KA; Link JM; Lewellen TK; Lewellen B; Freeman SD; Berger MS; Ojemann GA
J Nucl Med; 1998 Mar; 39(3):440-8. PubMed ID: 9529289
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber W; Bartenstein P; Gross MW; Kinzel D; Daschner H; Feldmann HJ; Reidel G; Ziegler SI; Lumenta C; Molls M; Schwaiger M
J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
[TBL] [Abstract][Full Text] [Related]
6. Brain imaging of glucose utilization in cerebral tumors.
Di Chiro G
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():185-97. PubMed ID: 3875134
[No Abstract] [Full Text] [Related]
7. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography.
Brooks DJ; Beaney RP; Lammertsma AA; Herold S; Turton DR; Luthra SK; Frackowiak RS; Thomas DG; Marshall J; Jones T
J Cereb Blood Flow Metab; 1986 Apr; 6(2):230-9. PubMed ID: 3007547
[TBL] [Abstract][Full Text] [Related]
8. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
[TBL] [Abstract][Full Text] [Related]
9. Effects of hyperglycemia on FDG uptake in human brain and glioma.
Ishizu K; Nishizawa S; Yonekura Y; Sadato N; Magata Y; Tamaki N; Tsuchida T; Okazawa H; Miyatake S; Ishikawa M
J Nucl Med; 1994 Jul; 35(7):1104-9. PubMed ID: 8014665
[TBL] [Abstract][Full Text] [Related]
10. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
[TBL] [Abstract][Full Text] [Related]
11. Perfusion and metabolism in predicting the survival of patients with cerebral gliomas.
Mineura K; Sasajima T; Kowada M; Ogawa T; Hatazawa J; Shishido F; Uemura K
Cancer; 1994 May; 73(9):2386-94. PubMed ID: 8168042
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of regional blood flow, blood volume, oxygen and glucose metabolism in heterogeneous parts of untreated high grade gliomas using positron emission tomography (PET)].
Sasajima T; Mineura K; Kowada M; Shishido F; Uemura K
No Shinkei Geka; 1989 Nov; 17(11):1005-13. PubMed ID: 2594150
[TBL] [Abstract][Full Text] [Related]
13. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
Rozental JM; Levine RL; Nickles RJ
J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
[TBL] [Abstract][Full Text] [Related]
14. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
16. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
Mishina M; Senda M; Ohyama M; Ishii K; Kitamura S; Terashi A
Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
[TBL] [Abstract][Full Text] [Related]
17. FDG transport and phosphorylation in human gliomas measured with dynamic PET.
Herholz K; Rudolf J; Heiss WD
J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262
[TBL] [Abstract][Full Text] [Related]
18. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography.
Tyler JL; Diksic M; Villemure JG; Evans AC; Meyer E; Yamamoto YL; Feindel W
J Nucl Med; 1987 Jul; 28(7):1123-33. PubMed ID: 3496433
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]